EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, QURE: Uniqure N.V.

16 Jun 26 14:09
LAST:

27.18

CHANGE:
 0.66		OPEN:
28.49		HIGH:
28.49		ASK:
16.75		VOLUME:
275.6K
CHG(%):
2.37		PREV:
27.84		LOW:
26.65		BID:
14.81		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
16 Jun 2628.4928.4926.6527.18275.6K
15 Jun 2627.7528.5027.2627.871.09M
12 Jun 2626.8728.7126.8027.57836.7K
11 Jun 2626.6927.6926.0126.821.31M
10 Jun 2626.1127.4425.9726.821.12M
09 Jun 2627.3327.5025.6526.461.18M
08 Jun 2626.8527.7626.7827.00761.1K
05 Jun 2627.6328.1926.3026.451.45M
04 Jun 2630.0131.0027.9027.993.18M
03 Jun 2627.0230.4526.9029.882.94M

PROFILE

Name:Uniqure N.V.
About:uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Sector:Healthcare
Industry:Biotechnology
Address:Paasheuvelweg 25, Amsterdam, Netherlands, 1105 BP
Website:https://www.uniqure.com
CUSIP:N90064101
CIK:0001590560
ISIN:NL0010696654
FIGI:BBG005SSJYH3

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-6.97 
Forward P/E:-6.40 
PEG Ratio:0.17 
Price to Sales:290.85 
Price to Book:5.42 
Profit Margin:0.32 
Operating Margin:-7.91 
Return on Assets:-0.15 
Return on Equity:-4.27 
EPS Ratio:-3.46 
Revenue:14.34M 
Shares:62.53M 
Market Cap:1.70B 

TECHNICAL INDICATORS

MA5:27.240.2%
MA10:27.400.8%
MA20:26.552.4%
MA50:22.9018.7%
MA100:21.1328.6%
MA200:27.230.2%
STO9:14.95 
STO14:37.07
RSI14:56.30
WPR14:-54.67
MTM14:2.28
ROC14:0.09 
ATR:2.12 
Week High:28.715.6%
Week Low:25.656.0%
Month High:31.0014.1%
Month Low:24.000.2%
Year High:71.50163.1%
Year Low:8.73211.3%
Volatility:8.67 

RECENT SPLITS

Date Ratio
31 Jan 20141-5